Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico

American Journal of Gastroenterology

Volumn 99, Issue 9, 2004, Pages 1774-1778

  Okhuysen, Pablo C ^a   Jiang, Zhi Dong ^b   Carlin, Lily ^b   Forbes, Charles ^b   DuPont, Herbert L ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI ENTEROTOXIN;

ABDOMINAL PAIN; ARTICLE; CONTROLLED STUDY; DIARRHEA; ESCHERICHIA COLI; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MEXICO; NONHUMAN; PRIORITY JOURNAL; QUESTIONNAIRE; SYMPTOM; TRAVELLER DIARRHEA; UNITED STATES;

ADULT; CHRONIC DISEASE; COHORT STUDIES; COLONIC DISEASES, FUNCTIONAL; DIARRHEA; FECES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; IRRITABLE BOWEL SYNDROME; MALE; MEXICO; NORTH AMERICA; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TRAVEL;

EID: 4544229494     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.30435.x     Document Type: Article

References (39)

1. Camilleri M, Heading RC, Thompson WG. Clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome. Aliment Pharmacol Therap 2002;16:1407-30.
2. Cook I, van Eeden A, Collins S. Patients with irritable bowel syndrome have greater pain tolerance than normal subjects. Gastroenterology 1987;93:727-33.
3. Ritchie J. Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut 1973;14:125-32.
4. Mertz H, Naliboff B, Munakata J, et al. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995;109:40-52.
5. Schmulson M, Lee OY, Chang L, et al. Symptom differences in moderate to severe IBS patients based on predominant bowel habit. Am J Gastroenterol 1999;94:2929-35.
6. Quigley EM. Current concepts of the irritable bowel syndrome. Scand J Gastroenterol (suppl) 2003:2371-8.
7. Mayer E, Collins S. Evolving pathophysiologic models of functional gastrointestinal disorders. Gastroenterology 2002;122:2032-48.
8. Lee E, Schiller L, Fordtran J. Quantification of colonic lamina propria cells by means of a morphometric point-counting method. Gastroenterology 1988:94409-18.
9. O'Sullivan M, Clayton N, Breslin NP, et al. Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil 2000;12:449-57.
10. Dunlop SP, Jenkins D, Spiller RC. Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol 2003;98:1578-83.
11. Zar S, Kumar D. Role of food hypersensitivity in irritable bowel syndrome. Minerva Medica 2002;93:403-12.
12. Gonsalkorale WM, Perrey C, Pravica V, et al. Interleukin 10 genotypes in irritable bowel syndrome: Evidence for an inflammatory component? Gut 2003;52:91-3.
13. Cumberland P, Sethi D, Roderick PJ, et al. The infectious intestinal disease study of England: A prospective evaluation of symptoms and health care use after an acute episode. Epidemiol Infect 2003;130:453-60.
14. Camilleri M. What's in a name? Roll on Rome II. Gastroenterology 1998;114:237.
15. Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut 1999;45:43ii-7.
16. Murray BE, Mathewson JJ, DuPont HL, et al. Utility of oligodeoxyribonucleotide probes for detecting enterotoxigenic Escherichia coli. J Infect Dis 1987;155:809-11.
17. Nataro JP, Baldini MM, Kaper JB, et al. Detection of an adherence factor of enteropathogenic Escherichia coli with a DNA probe. J Infect Dis 1985;152:560-5.
18. Chaudhary N, Truelove S. The irritable colon syndrome: A study of the clinical features, predisposing causes, and prognosis in 130 cases. Q J Med 1962:307-22.
19. Urfer E, Rossier P, Mean F, et al. Outbreak of Salmonella braenderup gastroenteritis due to contaminated meat pies: Clinical and molecular epidemiology. Clin Microbiol Infect 2000;6:536-42.
20. McKendrick MW, Read NW. Irritable bowel syndrome-Postsalmonella infection. J Infect 1994;29:1-3.
21. Bergin A, Donnelly MA, McKendrick MW. Changes in anorectal function in persistent bowel disturbance following salmonella gastroenteritis. Eur J Gastroenterol Hepatol 1993;5:617-20.
22. Rodriguez LA, Ruigomez A. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: Cohort study. Br Med J 1999;318:565-6.
23. Parry SD, Stansfield R, Jelley D, et al. Is irritable bowel syndrome more common in patients presenting with bacterial gastroenteritis? A community-based, case-control study. Am J Gastroenterol 2003;98:327-31.
24. Spiller RC, Jenkins D, Thornley JP, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000;47:804-11.
25. Thornley JP, Jenkins D, Neal K, et al. Relationship of Campylobacter toxigenicity in vitro to the development of postinfectious irritable bowel syndrome. J Infect Dis 2001;184:606-9.
26. Neal KR, Hebden J, Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: Postal survey of patients. Br Med J 1997;314:779-82.
27. Gwee KA, Collins SM, Read NW, et al. Increased rectal mucosal expression of interleukin 1 beta in recently acquired post-infectious irritable bowel syndrome. Gut 2003;52:523-6.
28. D'Anchino M, Orlando D, De Feudis L. Giardia lamblia infections become clinically evident by eliciting symptoms of irritable bowel syndrome. J Infect 2002;45:169-72.
29. Bujanda L, Gutierrez-Stampa MA, Caballeros CH, et al. Trastornos gastrointestinales en Guatemala y su relacion con infecciones parasitarias. Anales de Medicina Interna 2002;19:179-82.
30. Ilnyckyj A, Balachandra B, Elliott L, et al. Post-traveler's diarrhea irritable bowel syndrome: A prospective study. Am J Gastroenterol 2003;98:596-9.
31. Gwee K-A, Leong Y-L, Graham C, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999;44:400-6.
32. Farthing MJG. Fortnightly review: Irritable bowel, irritable body, or irritable brain? Br Med J 1995;310:171-5.
33. Gwee K, Graham J, McKendrick M, et al. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet 1996;347:150-3.
34. Bouckenooghe AR, Dupont HL, Jiang ZD, et al. Markers of enteric inflammation in enteroaggregative Escherichia coli diarrhea in travelers. Am J Trop Med Hyg 2000;62:711-13.
35. Greenberg DE, Jiang ZD, Steffen R, et al. Markers of inflammation in bacterial diarrhea among travelers, with a focus on enteroaggregative Escherichia coli pathogenicity. J Infect Dis 2002;185:944-9.
36. Jiang Z-D, Okhuysen PC, Guo D, et al. Genetic susceptibility to enteroaggregative Escherichia coli diarrhea-polymorphism in the interleukin 8 promoter region. J Infect Dis 2003;188:506-11.
37. Barbara G, Stanghellini V, Berti-Ceroni C. Role of antibiotic therapy on long term fecal excretion and digestive symptoms after Salmonella infection. Aliment Pharmacol Therap 2000;14:1127-31.
38. King TS, Ella M, Hunter JO. Abnormal colonic fermentation in irritable bowel syndrome. Lancet 1998;352:1187-9.
39. Pimentel M, Soffer EE, Chow EJ, et al. Lower frequency of MMC is found in IBS subjects with abnormal lactulose breath test, suggesting bacterial overgrowth. Dig Dis Sci 2002;47:2639-43